Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH is an important intermediate for polypeptide synthesis. It is mainly used to introduce histidine, Aib, glutamic acid, and glycine into polypeptides to enhance the stability or functional properties of the polypeptides. It has broad application value in the fields of drug research and development, biochemical research, as well as metal coordination or catalysis.
*The following content is generated by AI and is for reference only.
Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH is a specialized protected peptide derivative widely utilized in the field of medicinal chemistry and organic synthesis. This compound features a specific sequence comprising N-terminal protection by a tert-butyloxycarbonyl (Boc) group on Histidine, which is further side-chain protected with a trityl (Trt) moiety to ensure regioselectivity during synthesis. The third residue is alpha-aminoisobutyric acid (Aib), a non-proteinogenic amino acid known for inducing rigid helical structures, followed by Glutamic acid with its carboxyl side chain protected as an tert-butyl ester (OtBu). The C-terminus terminates with Glycine bearing a free carboxylic acid group. While a unique CAS registry number for this exact custom synthetic intermediate may not be publicly indexed in standard commercial databases due to its nature as a specific research reagent, it serves as a critical building block for the solid-phase peptide synthesis (SPPS) of complex bioactive molecules. Its primary application lies in the construction of peptidomimetics and potential therapeutic agents designed to exhibit enhanced metabolic stability and specific conformational constraints compared to natural peptides. The inclusion of Aib often confers resistance to proteolytic degradation, making such derivatives valuable candidates for drug development targeting various physiological pathways. Researchers employ this molecule in fragment condensation strategies or as a key intermediate for synthesizing cyclic peptides, enzyme inhibitors, or antimicrobial agents. Strict adherence to inert atmosphere conditions is recommended during handling to prevent premature deprotection or hydrolysis. Ultimately, Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH represents a sophisticated tool for chemists aiming to explore structure-activity relationships (SAR) and develop next-generation pharmaceuticals with optimized pharmacokinetic profiles.
(All Rights Reserved)![6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one](https://eimg.pharmasources.com/image/20250617/4zoOybJjzUTk0UgguabMkX7VnrDIlxHluERwqkjK.jpg)
![8-Oxa-1,3-diazaspiro[4.5]decane-2,4-dione](https://eimg.pharmasources.com/image/product/20250403/60fa7223d5a34f24138486ceea0ffb15jpg)
![8,16-Diazadispiro[6.1.6.2]heptadecan-17-one](https://eimg.pharmasources.com/image/product/20250403/ca91cba8b87e53fc879f8d8764873a40jpg)
![6,8-Dioxo-5,7-diazaspiro[3.4]octane-2-carboxylic acid](https://eimg.pharmasources.com/image/product/20250403/02effeb5a7639bc84ff1f3add3c0c64fjpg)
